This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q79163253
rdf:type
wikibase:Item
schema:description
scientific article published on 29 September 2006 artículu científicu espublizáu en setiembre de 2006 наукова стаття, опублікована у вересні 2006 im September 2006 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q79163253-6B2FFA7F-C9CF-4E10-B813-04A79867EF9A
wdt:P577
2006-09-29T00:00:00Z
p:P407
wds:Q79163253-BF94848A-FB13-41EF-BBB0-CA11D0206311
wdt:P407
wd:Q1860
p:P2860
wds:Q79163253-F36C6B9E-5E9F-4B3D-86A3-02D3FCF0A714
wdt:P2860
wd:Q41679901
p:P2093
wds:Q79163253-89D5B39A-A6D7-4467-94AB-DFA90CB16D8E
wdt:P2093
Rault S
rdfs:label
Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents
skos:prefLabel
Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents
schema:name
Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents
p:P50
wds:Q79163253-7057BF7A-0FC3-41BE-A28A-FF719F405878 wds:Q79163253-286F010B-BF3A-45C3-8907-739D31BDECD0 wds:Q79163253-4A912B46-2463-4EA1-9B58-EE26E1BFB9DA
wdt:P50
wd:Q59006225 wd:Q58957254 wd:Q56808204
p:P1476
wds:Q79163253-F44E713F-A9D3-4CCB-B74A-724431E71F29
wdt:P1476
Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents
p:P304
wds:Q79163253-B87FF622-6FDF-4335-AB8F-C082446EA5BD
wdt:P304
8162-8175
p:P31
wds:Q79163253-55153133-4DF2-48C3-810C-9AA81BD13321
wdt:P31
wd:Q13442814
p:P698
wds:Q79163253-CEE71A52-136D-4EED-8C2C-9ED546D5C564
wdtn:P698
n12:17011196
wdt:P698
17011196
p:P1433
wds:Q79163253-394B74FF-3418-413A-B4C1-467FB0950C8C
wdt:P1433
wd:Q2904200
p:P433
wds:Q79163253-4FA4570C-F7D0-492C-A1AF-350985CA40C0
p:P478
wds:Q79163253-1FF3CB46-A616-4F1B-A88C-3C3416CA8FF9
wdt:P433
24
wdt:P478
14
p:P356
wds:Q79163253-96F56999-36E9-4B16-84A9-2C1D501AF998
wdtn:P356
n9:J.BMC.2006.09.022
wdt:P356
10.1016/J.BMC.2006.09.022